Trade AstraZeneca ^AZN

SG Americas Securities LLC Grows Stock Position in AstraZeneca PLC $AZN

Assessing Walmart (WMT) Valuation As Nasdaq 100 Entry And Tech Push Draw Fresh Attention

Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) - Here's Why

Walmart to join Nasdaq 100 from January 20 as AstraZeneca exits the index

Walmart to join Nasdaq 100 on Jan 20 as AstraZeneca exits - The Business Times

Walmart to replace AstraZeneca on Nasdaq-100 Index on January 20

Oak Family Advisors LLC Sells 23,242 Shares of AstraZeneca PLC $AZN

Cellectis Announces 2026 Strategy and Catalysts

Cellectis annonce sa stratégie et ses jalons attendus en 2026

AstraZeneca's (AZN) Overweight Rating Reaffirmed at JPMorgan Chase & Co. - Markets Daily

JPMorgan Chase & Co. Reiterates Overweight Rating for AstraZeneca (LON:AZN)

Park Avenue Securities LLC Boosts Stock Position in AstraZeneca PLC $AZN

Vaughan Nelson Investment Management L.P. Acquires Shares of 23,726 AstraZeneca PLC $AZN - Markets Daily

Vaughan Nelson Investment Management L.P. Makes New Investment in AstraZeneca PLC $AZN - Daily Political

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 35% One-Year Rally?

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

AstraZeneca (LON:AZN) Sets New 52-Week High - Still a Buy?

AstraZeneca (LON:AZN) Stock Crosses Above 200-Day Moving Average - Should You Sell?

European Shares Seen Mostly Higher In Cautious Trade

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Quality quartet sprinkle more gold dust on glittering Awards sponsor line-up

Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

AstraZeneca (NASDAQ:AZN) Sets New 1-Year High - What's Next?

AZN: Oncology And Biopharma Execution Will Offset Patent Pressure Concerns

Is China's ENHERTU Approval in HR-positive HER2-low Breast Cancer Altering The Investment Case For Daiichi Sankyo Company (TSE:4568)?

Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study

AstraZeneca PLC $AZN Stake Boosted by Allspring Global Investments Holdings LLC

The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

Taking Stock of AstraZeneca (LSE:AZN): Is Its 31% One-Year Return Now Fully Valued?

AstraZeneca (NASDAQ:AZN) Upgraded to Strong-Buy at Wall Street Zen

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

Q4 EPS Estimates for AstraZeneca Boosted by Zacks Research

Optimizing cardiovascular pharmacotherapy in older adults with frailty

My Personal CFO LLC Acquires Shares of 38,411 AstraZeneca PLC $AZN

I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…

Zacks Research Raises Earnings Estimates for AstraZeneca - Stock Observer

25,322 Shares in AstraZeneca PLC $AZN Purchased by Moody Lynn & Lieberson LLC

Smith Salley Wealth Management Raises Stock Holdings in AstraZeneca PLC $AZN

Ethic Inc. Acquires 11,638 Shares of AstraZeneca PLC $AZN

Regulatory actions for Dec. 30, 2025 | BioWorld

DAVENPORT & Co LLC Increases Stake in AstraZeneca PLC $AZN

China's rising biotech clout on show in flurry of billion-dollar licensing deals | South China Morning Post

Robbins Farley Purchases 27,582 Shares of AstraZeneca PLC $AZN

Jacobio, AstraZeneca ink cancer drug deal - Chinadaily.com.cn

AstraZeneca Reaches Settlement With MSN Labs Over Cancer Drug

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications

Pharma Giants Compete to Unveil First Effective Weight-Loss Pill, ETPharma

Factbox-Top pharma companies racing to launch first weight-loss pill

Did ChatGPT give me the best FTSE stocks to buy 1 year ago?

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

Cambridge Cluster companies build global status and hook more than $2 billion funding in 2025

Health Care Up as Traders Rotate Back Into Sector - Health Care Roundup | Morningstar

AstraZeneca Sues US Over Drugs for Medicare Price Cuts Round 2

AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock - Markets Daily

AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock

AstraZeneca's Ceralasertib-Imfinzi Combination Fails Lung Cancer Trial, ETPharma

Jacobio signs $1.9B deal with Astrazeneca for pan-KRAS inhibitor | BioWorld

Jacobio licenses pan KRAS inhibitor to AstraZeneca

China's Jacobio inks immuno-oncology deal worth $1.9 B with AstraZeneca

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

Jacobio Pharma Signs Agreement With AstraZeneca On Pan-KRAS Inhibitor JAB-23E73

AstraZeneca PLC $AZN Position Boosted by Benson Investment Management Company Inc.

Flputnam Investment Management Co. Increases Holdings in AstraZeneca PLC $AZN - Daily Political

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union

16,277 Shares in AstraZeneca PLC $AZN Bought by Montecito Bank & Trust

Voya Investment Management LLC Buys 770,417 Shares of AstraZeneca PLC $AZN - Daily Political

AstraZeneca's Breast Cancer Drug Datopotamab Deruxtecan Approved in India, ETPharma

15 stocks to watch on Friday: Lupin, Ola, AstraZeneca, Shriram Finance

AstraZeneca Fails to Block Colorado Contract Pharmacy Regulation

Assenagon Asset Management S.A. Sells 569,162 Shares of AstraZeneca PLC $AZN

10 Newly Overvalued Stocks this Month | Morningstar Nordics

The Bull Case For Salesforce (CRM) Could Change Following Broad Agentforce 360 Wins Across Key Sectors

Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

Rep. Gilbert Ray Cisneros, Jr. Buys AstraZeneca PLC (NASDAQ:AZN) Stock

Sanders Morris Harris LLC Invests $950,000 in AstraZeneca PLC $AZN

B. Riley Wealth Advisors Inc. Invests $776,000 in AstraZeneca PLC $AZN

Recent Investment Analysts' Ratings Updates for AstraZeneca (AZN) - Markets Daily

University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare | PressReleasePoint

AstraZeneca PLC ADRhedged (BATS:AZNH) Declares $0.58 Annual Dividend - Markets Daily

AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

AstraZeneca Announces Approval Of Saphnelo In The EU

AstraZeneca PLC $AZN Shares Acquired by Park National Corp OH - Stock Observer

AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US

Beyfortus (Nirsevimab) now available in Malaysia to help protect all infants against RSV disease | Malay Mail

FDA Approves Enhertu and Perjeta Combination for First-Line HER2-Positive Breast Cancer Treatment, ETPharma

Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk